Back to search
FDAFDA · Food and drugs·Recall number D-1135-2018

Valsartan Tablets USP, 160mg, 90 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-069-90

Published September 5, 2018 · Recall initiated: August 17, 2018

Summary

FDA records drug Class II recall D-1135-2018, published September 5, 2018 and initiated August 17, 2018. Recalling firm: Torrent Pharma Inc.; Status: Ongoing; Reported quantity: 14016 bottles; Lot: Batch: BV47C005, BV47C006, BV47D001, BV47C003, BV47C004. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Torrent Pharma Inc.
Distributor
Nationwide USA
Lot
Batch: BV47C005, BV47C006, BV47D001, BV47C003, BV47C004
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Valsartan Tablets USP, 160mg, 90 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-069-90 recalled?

Yes. FDA published recall D-1135-2018 on September 5, 2018. Reported hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

What should I do if I have this product?

Voluntary: Firm initiated · Letter